HRAS Q61L
|
SCCHN
|
HRAS Q61L
|
SCCHN
|
trametinib Sensitive: D – Preclinical
|
trametinib Sensitive: D – Preclinical
|
HRAS Q61L
|
SCCHN
|
HRAS Q61L
|
SCCHN
|
tipifarnib Sensitive: D – Preclinical
|
tipifarnib Sensitive: D – Preclinical
|
HRAS Q61L
|
SCCHN
|
HRAS Q61L
|
SCCHN
|
PF-05212384 Sensitive: D – Preclinical
|
PF-05212384 Sensitive: D – Preclinical
|
HRAS Q61L
|
SCCHN
|
HRAS Q61L
|
SCCHN
|
cetuximab Resistant: D – Preclinical
|
cetuximab Resistant: D – Preclinical
|